Mereo BioPharma Files Annual Report
Ticker: MREO · Form: ARS · Filed: 2026-04-09T06:52:50-04:00
Sentiment: neutral
Topics: annual-report, sec-filing, biopharma
TL;DR
Mereo BioPharma filed its 2025 ARS on 4/9/26. Check it out.
AI Summary
Mereo BioPharma Group plc filed an Annual Report to Security Holders (ARS) on April 9, 2026, for the period ending December 31, 2025. The company, headquartered in London, United Kingdom, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing provides shareholders with an update on the company's performance and financial standing for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual filing and does not indicate any immediate or specific risks.
Key Numbers
- 760465 — ARS PDF Size (Size of the Annual Report to Security Holders PDF document.)
- 1048943 — Text File Size (Size of the complete submission text file.)
Key Players & Entities
- Mereo BioPharma Group plc (company) — Filer of the ARS
- 0001719714 (company) — CIK number for Mereo BioPharma Group plc
- 2026-04-09 (date) — Filing date of the ARS
- 2025-12-31 (date) — Period of report for the ARS
FAQ
What is the primary purpose of an ARS filing?
An ARS filing, or Annual Report to Security Holders, is used by companies to provide shareholders with a comprehensive overview of their business and financial performance over the past fiscal year.
When was this specific ARS filing accepted by the SEC?
This ARS filing was accepted by the SEC on April 9, 2026.
What fiscal period does this ARS filing cover?
This ARS filing covers the period ending December 31, 2025.
What is the CIK number for Mereo BioPharma Group plc?
The CIK number for Mereo BioPharma Group plc is 0001719714.
What industry is Mereo BioPharma Group plc primarily involved in?
Mereo BioPharma Group plc is primarily involved in the Pharmaceutical Preparations industry (SIC code 2834).
From the Filing
EDGAR Filing Documents for 0001193125-26-148835 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form ARS - Annual Report to Security Holders: SEC Accession No. 0001193125-26-148835 Filing Date 2026-04-09 Accepted 2026-04-09 06:52:50 Documents 1 Period of Report 2025-12-31 Effectiveness Date 2026-04-09 Document Format Files Seq Description Document Type Size 1 ARS mreo_2025_ars_filed.pdf ARS 760465 Complete submission text file 0001193125-26-148835.txt 1048943 Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON United Kingdom W1G 0QF Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON United Kingdom W1G 0QF 4403330237300 Mereo BioPharma Group plc (Filer) CIK : 0001719714 (see all company filings) EIN. : 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231 Type: ARS | Act: 34 | File No.: 001-38452 | Film No.: 26849774 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)